ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2021 American Transplant Congress

    Donor-Derived Cell-Free DNA as a Surrogate Marker for “Allograft Quiescence” After Kidney Transplantation

    J. S. Bromberg1, L. Bu2, G. Gupta3, I. Moinuddin3, S. Anand4, A. Pai5, T. Alhamad6, V. Bowers7, S. Ghosh8, W. Tian8, E. Stites9

    1University of Maryland School of Medicine, Baltimore, MD, 2University of Minnesota, Minneapolis, MN, 3Virginia Commonwealth University, Richmond, VA, 4Intermountain Medical Center, Murray, UT, 5University of Texas McGovern Medical School, Houston, TX, 6Washington University in St. Louis, St. Louis, MO, 7Tampa General Hospital, Tampa, FL, 8CareDx, Brisbane, CA, 9University of Colorado, Aurora, CO

    *Purpose: Donor-derived cell-free DNA (dd-cfDNA; AlloSure®) and the association with active rejection (AR) was described by Bloom et al, however subsequent insights have suggested this…
  • 2021 American Transplant Congress

    Donor Derived Cell-Free DNA (dd-cfDNA) in Pancreas Transplant Recipients

    S. Riad1, H. Sarumi2, R. Kandaswamy3

    1Medicine, University of Minnesota, Minneapolis, MN, 2Surgery, University of Minnesota Physicians, Minneapolis, MN, 3Surgery, University of Minnesota, Minneapolis, MN

    *Purpose: Data on the role of DD-cfDNA after pancreas transplantation is lacking. Herein we report on our center experience with DD-cfDNA in 10 unique SPK…
  • 2021 American Transplant Congress

    Steroid-free Immunosuppression in Heart-Kidney Transplant Patients: Is It Safe?

    R. Skorka, J. Patel, M. Kittleson, N. Patel, T. Singer-Englar, A. Velleca, B. Azarbal, D. Chang, E. Kransdorf, L. Czer, D. Megna, J. A. Kobashigawa

    Cedars-Sinai Smidt Heart Institute, Los Angeles, CA

    *Purpose: Simultaneous heart and kidney transplantation (sHKTx) has increased in numbers over the past 10 years. There are reports that the kidney protects the heart…
  • 2021 American Transplant Congress

    DSA is Associated with Molecular Changes in Many Hearts with Minor Abnormalities but Not Diagnosed as Antibody-Mediated Rejection

    P. Halloran1, K. S. Madill-Thomsen1, &. the INTERHEART Study Group2

    1Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada, 2., ., AB, Canada

    *Purpose: We previously developed a microarray-based diagnostic system (MMDx) for heart transplant endomyocardial biopsies, measuring gene expression and interpreting antibody-mediated and T cell-mediated rejection (ABMR,…
  • 2021 American Transplant Congress

    The Effect of the Different Donor-Derived HLA T-Cell Epitope Targets on the Development of T Cell-Mediated Rejection After Kidney Transplantation

    A. Senev, E. Van Loon, M. Emonds, M. Naesens

    Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium

    *Purpose: Many kidney allografts fail due to rejections caused by the donor and recipient HLA incompatibility. Recent studies have shown that HLA-DR and DQ mismatches…
  • 2021 American Transplant Congress

    Clinical Value of Surveillance Biopsies in Pediatric Liver Transplantation: A Single Center Experience with >800 Biopsies

    B. Rocque1, A. Zaldana1, C. Weaver2, J. Huang1, A. Barbetta1, V. Shakhin2, C. Goldbeck1, G. Yanni2, R. Kohli2, Y. Genyk1, J. Emamaullee1

    1Surgery, University of Southern California Keck School of Medicine, Los Angeles, CA, 2Pediatrics, Children’s Hospital-Los Angeles, Los Angeles, CA

    *Purpose: While pediatric liver transplantation (LT) results in excellent long-term outcomes, a high incidence of early acute cellular rejection (ACR) and late graft fibrosis persists.…
  • 2021 American Transplant Congress

    Interruption of Notch Signaling via Blockade of Delta-Like Ligand 4 Prevents Co-Stimulation Blockade Resistant Allograft Rejection

    A. J. Matar, B. P. Lovasik, Y. Dong, D. A. Faber, J. Habib, C. Breeden, J. Regenold, A. Ghosh, A. Stephenson, W. H. Kitchens, A. B. Adams

    Emory University Department of Surgery, Atlanta, GA

    *Purpose: Co-stimulation blockade (CoB) has emerged as a promising immunosuppression strategy with the advent of Belatacept, a novel CTLA4-Ig fusion protein that blocks CD28-mediated T…
  • 2021 American Transplant Congress

    Transforming Growth Factor-Beta Induced Myeloid-Derived Suppressor Cells Promote Transplant Immune Tolerance

    F. Zhang

    Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China, Beijing, China

    *Purpose: Myeloid-derived suppressor cells (MDSCs) are a group of heterogeneous cells derived from bone marrow with immunosuppressive effect, which contribute to the establishment of transplant…
  • 2021 American Transplant Congress

    Donor Derived Cell-free-dna (dd-cfdna) as a Surrogate Marker for Kidney Biopsy- Indiana University Transplant Nephrology Experience

    S. Valavoor1, A. Sharfuddin2, G. William3, M. Yaqub1, D. Mishler1, O. Adebiyi2

    1Nephrology, Indiana University, Indianapolis, IN, 2Transplant Nephrology, Indiana University, Indianapolis, IN, 3Transplant Surgery, Indiana University, Indianapolis, IN

    *Purpose: Patient monitoring after kidney transplantation (KT) for early detection of allograft rejection remains key in preventing allograft loss. Donor-derived cell-free DNA (dd-cfDNA), a noninvasive…
  • 2021 American Transplant Congress

    Dosing Weight of Rabbit Antithymocyte Globulin and Outcomes Among Kidney Transplant Patients Treated for Rejection

    C. Patton, K. Cunningham, C. D'Agostino, A. Novak, M. Kapugi, K. Lang, C. Kane

    Pharmacy, Northwestern Memorial Hospital, Chicago, IL

    *Purpose: Rabbit antithymocyte globulin (rATG) is FDA approved for kidney transplant induction therapy and treatment of T-cell mediated rejection (TCMR). While prior studies comparing dosing…
  • « Previous Page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences